Beginning this month, Aetna and Medtronic, Inc. will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may improve their health using insulin pump therapy.

Eligible members will receive targeted education, case management, and other patient support to help control blood sugar, which also may lower their healthcare costs. Information gathered from the program also is expected to help doctors and other health care providers more easily identify and support those who can benefit most from this therapy.